Three things to know:
1. Deal values tripled in the first quarter of this year compared to the last quarter of 2018, driven by Centene’s $17.4 billion bid for WellCare Health Plans. That proposed merger reflected 57.5 percent of the quarter’s value.
2. When excluding megadeals — defined by PwC as those over $5 billion — deal value grew 33.5 percent in the first quarter when compared to the last quarter of 2018. Year over year, first quarter deal value grew 122.8 percent.
3. At the same time, deal volume fell in the first quarter of 2019 compared to the prior quarter and year by 28.3 percent and 21.2 percent, respectively. PwC said the drop “should not necessarily be seen as suggestive of future declines.”
More articles on healthcare transactions:
Judge approves KPC Group’s bid to acquire 4 Verity hospitals
3 experts break down the past, present & future of consolidation
Quarterly hospital M&A reaches lowest volume in nearly a decade
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
